Wednesday, April 21, 2021

admin

1115 POSTS2 COMMENTS

Chemotherapy-free treatment option to be offered to patients with England’s most common leukaemia

April 21, 2021: A brand new oral treatment for an incurable blood cancer has been recommended for NHS use by NICE.

GW Pharma receives EU approval for EPIDYOLEX® for treatment of seizures

April 20, 2021: "GW Pharmaceuticals, a world leader in discovering, developing and delivering regulatory approved cannabis-based medicinesannounces that the European Commission has...

Amgen Successfully Completes Acquisition Of Five Prime Therapeutics

April 16, 2021: "Amgen announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares of...

JCVI issues new advice on COVID-19 vaccination for pregnant women

April 16, 2021: There have been no specific safety concerns identified with any brand of coronavirus (COVID-19) vaccines in relation to pregnancy. 

Phico Therapeutics gains £13.1m grant to advance antibacterial therapy

March 19, 2021: "Phico Therapeutics Ltd, a biotechnology companydeveloping engineered phage technology as the basis of a new generation of antibiotics to...

EU approves second indication of Sarclisa® for relapsed multiple myeloma

April 19 2021: "The European Commission approved Sarclisa® (isatuximab) in combination with carfilzomib and dexamethasone (Kd) for the treatment of adult patients with...

AstraZeneca receives US clearance of proposed acquisition of Alexion

April 16, 2021: "AstraZeneca’s proposed acquisition of Alexion Pharmaceuticals, Inc (Alexion) has achieved an important step toward completion, having cleared US Federal Trade...

Update of the WHO guidance on the treatment of drug susceptible tuberculosis

April 16, 2021: The WHO is convening a Guideline Development Group (GDG) to advise on updates needed to its recommendations on the...

FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab

April 16, 2021: "The U.S. FDA revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone,...

FDA Approves First Immunotherapy for Initial Treatment of Gastric Cancer

April 16, 2021:The U.S. Food and Drug Administration approved Opdivo (nivolumab), in combination with certain types of chemotherapy, for the initial treatment...

Alchemab raises £60M A financing to advance novel platform

Apr 15, 2021: "Alchemab Therapeutics, a biotech company developing novel products for patients with hard-to-treat diseases by harnessing the power of naturally...

Amylyx Pharmaceuticals provides global regulatory update on amx0035 for ALS

April 14, 2021: Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis (ALS), Alzheimer’s Disease and...

TOP AUTHORS

1115 POSTS2 COMMENTS

Most Read

Chemotherapy-free treatment option to be offered to patients with England’s most common leukaemia

April 21, 2021: A brand new oral treatment for an incurable blood cancer has been recommended for NHS use by NICE.

GW Pharma receives EU approval for EPIDYOLEX® for treatment of seizures

April 20, 2021: "GW Pharmaceuticals, a world leader in discovering, developing and delivering regulatory approved cannabis-based medicinesannounces that the European Commission has...

Amgen Successfully Completes Acquisition Of Five Prime Therapeutics

April 16, 2021: "Amgen announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares of...

JCVI issues new advice on COVID-19 vaccination for pregnant women

April 16, 2021: There have been no specific safety concerns identified with any brand of coronavirus (COVID-19) vaccines in relation to pregnancy.